Miriam K.
- Country
- Germany
- Department
- Zentrum für Innere Medizin III
Research Overview
- Phase I/IIa Study of Belantamab Mafodotin and Venetoclax in Relapsed/Refractory t(11;14) Multiple Myeloma Patients
- A Phase 3, Two-stage, Randomized, Multicenter, Open-label Study Comparing Mezigdomide (CC-92480/BMS-986348), Carfilzomib, and Dexamethasone (MeziKd) Versus Carfilzomib and Dexamethasone (Kd) in Participants with Relapsed or Refractory Multiple Myeloma (RRMM): SUCCESSOR-2
- Randomized Phase II Study of Teclistamab + Daratumumab‑Lenalidomide‑Dexamethasone (Tec‑DRd) vs Daratumumab‑Lenalidomide‑Dexamethasone (DVRd) in Transplant‑Eligible NDMM
Data & Insights
Has run more than one trial at 206 of 372 partner sites.
Specializations
Multiple Myeloma Treatment Expertise
The investigator specializes in treating multiple myeloma, with particular focus on both newly diagnosed cases and relapsed/refractory disease states. Their research encompasses innovative therapeutic approaches including immunotherapy combinations and maintenance treatments.
- Novel Agent Combinations
- Post-Transplant Therapy
- Immunotherapeutic Approaches
Their work includes evaluating breakthrough treatments involving monoclonal antibodies and targeted therapies.
Stem Cell Transplantation Research
The investigator has significant expertise in autologous stem cell transplantation for hematologic malignancies. Their research focuses on optimizing treatment outcomes through various pre- and post-transplant therapeutic strategies.
- Transplant Response Assessment
- Maintenance Therapy Optimization
- Novel Conditioning Regimens
Their work examines innovative approaches to improve long-term outcomes following transplantation.
Germ Cell Tumor Treatment
The investigator conducts research in treating progressive and recurrent germ cell tumors, exploring various therapeutic strategies including conventional chemotherapy and high-dose treatment approaches.
- Salvage Treatment Protocols
- Chemotherapy Optimization
- Treatment Resistance Management
Their expertise extends to developing effective treatment strategies for refractory cases.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.